Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q1 2017)

As of Mar 31, 2017, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2017, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2017
39115V101
Great Panther
Sell
-1,448,100
Q1 2017
A
Agilent Technologies, Inc.
Sell
-207,100
Q1 2017
AA
Alcoa Corporation
Buy
+1,592,700
Q1 2017
AAME
Atlantic American Corporation
Buy
+600
Q1 2017
AAOI
Applied Optoelectronics, Inc.
Buy
+339,900
Q1 2017
AAON
AAON, Inc.
Sell
-33,200
Q1 2017
AAP
Advance Auto Parts Inc.
Buy
+129,600
Q1 2017
AB
AllianceBernstein Holding L.P.
Buy
+193,625
Q1 2017
ABBNY
ABB Ltd.
Buy
+595,737
Q1 2017
ABBV
AbbVie Inc.
Buy
+1,737,156
Q1 2017
ABCB
Ameris Bancorp
Sell
-31,600
Q1 2017
ABEV
Ambev S.A.
Sell
-9,564,819
Q1 2017
ABR
Arbor Realty Trust
Buy
+108,537
Q1 2017
ABT
Abbott Laboratories
Buy
+143,866
Q1 2017
ABUS
Arbutus Biopharma Corporation
Buy
+110,499
Q1 2017
AC
Associated Capital Group, Inc.
Sell
-19,601
Q1 2017
ACCO
Acco Brands Corporation
Buy
+149,800
Q1 2017
ACHC
Acadia Healthcare Company, Inc.
Sell
-695,300
Q1 2017
ACIC
American Coastal Insurance Corp
Sell - Position Exit
-15,300
Q1 2017
ACLS
Axcelis Technologies, Inc.
Sell - Position Exit
-19,950
Q1 2017
ACM
AECOM
Sell
-430,300
Q1 2017
ACN
Accenture plc
Sell - Position Exit
-485,410
Q1 2017
ACNB
ACNB Corporation
Buy
+5,639
Q1 2017
ACNT
Ascent Industries Co.
Sell
-8,900
Q1 2017
ACRE
Ares Commercial Real Estate Cor
Sell
-12,637
Q1 2017
ACRS
Aclaris Therapeutics, Inc.
Sell
-86,521
Q1 2017
ACTG
Acacia Research Corporation
Buy
+103,800
Q1 2017
ACU
Acme
Buy
+9,000
Q1 2017
ADAP
Adaptimmune Therapeutics plc
Buy
+335,700
Q1 2017
ADBE
Adobe Inc.
Sell
-165,333
Page 1 of 63